NASDAQ officials warned Exact Sciences Corp. to shape up or face a possible delisting from the exchange.
The Marlborough-based cancer gene testing firm failed to meet the exchange’s $35 million market capitalization minimum for 10 consecutive trading days. Market capitalization is the number of shares outstanding multiplied by the share price.
The company has until June 4 to right the ship or its common stock will be delisted from NASDAQ’s Capital Market.